S-1/A: Australian Oilseeds Holdings Reports Increased Revenue Amidst Expanding Retail Presence and Significant Losses, Faces Nasdaq Delisting Risk

Australian Oilseeds Holdings Limited, a cold-pressed oil producer, reported substantial revenue growth driven by new supermarket contracts but posted increased net losses and a significant net current liability, while also addressing a Nasdaq minimum bid price deficiency and outlining plans for a potential $50 million equity line of credit.

Summary

• Australian Oilseeds Holdings Limited (COOT) is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds, operating the largest cold-pressing oil plant in Australia.
• The company completed a Business Combination (de-SPAC merger) on March 21, 2024, with EDOC Acquisition Corp., resulting in COOT Ordinary Shares and Warrants (COOTW) commencing trading on Nasdaq on March 22, 2024.
• Sales revenue for the three months ended March 31, 2025, increased by AUD$3.1 million (49.8%) to AUD$9.4 million, compared to AUD$6.3 million for the same period in 2024.
• For the nine months ended March 31, 2025, sales revenue grew by AUD$4.1 million (16.1%) to AUD$30.1 million, up from AUD$25.9 million in the prior year period.
• Retail oils segment revenue significantly increased by AUD$1.9 million (69.4%) for the three months ended March 31, 2025, and by AUD$5.7 million (58.2%) for the nine months ended March 31, 2025, primarily due to new supply contracts with Costco Australia (15 stores), Woolworth Supermarkets (1,050 stores), and Coles Supermarket (850 stores).
• The company reported a net loss of AUD$630,633 for the three months ended March 31, 2025, compared to a profit of AUD$41,185 in the prior year period.
• For the nine months ended March 31, 2025, the net loss was AUD$1,597,298, a significant decline from a profit of AUD$2,422,104 in the prior year period.
• The company was in a net current liability position of AUD$9,622,311 as of March 31, 2025, worsening from AUD$6,965,530 as of June 30, 2024.
• Net cash outflow from operating activities was AUD$1,942,969 for the nine months ended March 31, 2025, compared to an inflow of AUD$1,259,485 for the same period in 2024.
• The company received a Nasdaq notification on August 28, 2024, regarding non-compliance with the $1 minimum bid price requirement, with a compliance period until February 24, 2025.
• Australian Oilseeds has the right to sell up to US$50,000,000 of its Ordinary Shares to Arena Business Solutions Global SPC II, Ltd. (Arena) over a 36-month period, subject to certain conditions, and will issue US$1,250,000 in Commitment Fee Shares to Arena upon the Registration Statement's effectiveness.
• The company is constructing a new crushing and production plant in Emerald, Central Queensland, projected to cost AUD$25 million, with government support of AUD$5 million in incentives and tax grants, and plans to raise AUD$8 million to AUD$11 million in equity funding for this project.
• The company has a history of net losses, including AUD$33,725,100 for the year ended June 30, 2024.
• JSKS Enterprises Pty Ltd., controlled by Gary Seaton (CEO), beneficially owns 58.4% of outstanding Ordinary Shares, making the company a 'controlled company' under Nasdaq rules.

Sentiment

Score: 3

Explanation: While the company shows strong revenue growth in key segments and has ambitious expansion plans backed by some government support and a potential large ELOC, its worsening net losses, significant net current liability, negative operating cash flow, and Nasdaq delisting risk indicate severe financial distress and high operational uncertainty. The positive growth is overshadowed by the substantial financial challenges and reliance on future capital raises.

Positives

• Total sales revenue increased by 49.8% for the three months ended March 31, 2025, and by 16.1% for the nine months ended March 31, 2025, demonstrating strong top-line growth.
• Retail oils segment showed significant growth, with revenue increasing by 69.4% and 58.2% for the three and nine months ended March 31, 2025, respectively, driven by new supply contracts with major Australian supermarkets like Costco, Woolworths, and Coles.
• The company is expanding its existing Cootamundra facility and constructing a new multi-seed crushing plant in Emerald, Queensland, which is expected to quadruple total processing capacity from 40,000 to 160,000 metric tons per annum, positioning it as the largest cold-pressed player in the APAC region.
• The Queensland plant project has secured AUD$5 million in government support (incentives and tax grants), indicating external validation and financial backing for strategic growth.
• The company's commitment to chemical-free, non-GMO, and sustainable edible oils aligns with growing global market demand for healthier and natural food products.
• The company has secured a US$50 million equity line of credit (ELOC) facility with Arena, providing a potential source of future funding for working capital and general corporate purposes.
• The company has obtained and maintains various certifications (FDA, Good Manufacturing Practices, Halal, Kosher, Non-GMO Project Verified) for its products, enhancing market credibility and access.
• The company's strategic location in Central Queensland for the new plant leverages a strong oilseed growing region, aiming to reduce freight costs and carbon emissions, and minimize distribution costs.

Negatives

• The company reported a net loss of AUD$630,633 for the three months ended March 31, 2025, and a loss of AUD$1,597,298 for the nine months ended March 31, 2025, indicating a worsening financial performance compared to prior periods.
• The company is in a significant net current liability position of AUD$9,622,311 as of March 31, 2025, which has increased from AUD$6,965,530 as of June 30, 2024, raising substantial doubt about its ability to continue as a going concern.
• Net cash outflow from operating activities was AUD$1,942,969 for the nine months ended March 31, 2025, a reversal from a net cash inflow in the prior year, indicating operational cash burn.
• Cost of sales increased by 55.7% for the three months and 30.8% for the nine months ended March 31, 2025, primarily due to higher material costs (canola seed), packaging, and labor, outpacing revenue growth in some periods.
• General and administrative expenses increased by 49.0% and 35.3% for the three and nine months ended March 31, 2025, respectively, driven by higher audit fees, insurance, and employee costs.
• Selling and marketing expenses saw a substantial increase of 366.8% for the three months ended March 31, 2025, reflecting increased spending on brand awareness.
• Finance expenses significantly increased by 190.4% and 232.7% for the three and nine months ended March 31, 2025, respectively, due to new asset finance loans, amortization of convertible note discount, and trade finance facility interest.
• The company is highly dependent on a small group of customers, with the top five customers accounting for 87.9% of total sales for the three months ended March 31, 2025, and the top three customers accounting for 57.8% of accounts receivable as of March 31, 2025, posing a concentration risk.
• The company received a Nasdaq notification on August 28, 2024, for non-compliance with the $1 minimum bid price rule, risking potential delisting if compliance is not regained.
• The company has a history of net losses, including AUD$33,725,100 for the year ended June 30, 2024, and may not achieve or maintain profitability in the foreseeable future.
• The company's business model is capital-intensive, and there is no assurance that additional capital will be available on attractive terms, if at all, which could be dilutive to shareholders.
• The company's management team has limited experience in operating a public company, which could lead to challenges in managing regulatory oversight and reporting obligations.

Risks

• Inability to predict the actual number of shares sold under the Purchase Agreement to Arena or the gross proceeds, and potential lack of access to the full US$50,000,000 available.
• Significant dilution to existing shareholders from the sale and issuance of Ordinary Shares to Arena, and potential decline in stock price due to actual or perceived sales by Arena.
• Investors buying shares at different times from Selling Securityholders may pay different prices and experience varying levels of dilution.
• Arena will purchase Ordinary Shares at a discounted price (97% of VWAP), which could cause the stock price to decline.
• The company is an early-stage company with a history of financial losses and expects to incur significant expenses and continuing losses for the foreseeable future.
• Significant dependence on revenues from the sale of cold-pressed vegetable oils and protein meals, making the company vulnerable to negative market changes in these product lines, including price increases in oilseeds.
• Lack of product and business diversification, making the company disproportionately affected by risks in the agricultural industry.
• Dependence on contracts with local and regional farmers for oilseeds; loss or non-renewal of these contracts, or decline in quality/quantity of supply, could materially affect business.
• Dependence on a material concentration of revenue from a small group of customers; loss of any key customer could adversely impact cash flows and revenue.
• Risks related to global, federal, state, and local regulations, including changes to trade restrictions, food safety, sustainability requirements, and environmental laws, which could materially affect operations and financial condition.
• Operations are subject to changing conditions like unfavorable weather (blight, bush fires, drought, flooding) and environmental conditions, which can decrease profitability and ability to meet product demands.
• Disruptions in water and power supply could adversely affect the company's and its suppliers' operations, impacting access to oilseeds.
• Operating results may fluctuate due to variations in product sales mix, competitive pricing, and increases in oilseed costs, utility costs, and raw material supply interruptions.
• Revenue may not achieve budget in FY 2025 due to capital expenditures for Cootamundra expansion and new Queensland facility construction, potentially impacted by factory breakdowns, overhauls, or spec adjustments.
• Failure to effectively promote the brand, particularly regarding GMO-free and chemical-free products, could harm reputation and reduce demand.
• Inability to hire and retain qualified personnel, especially senior management and technical staff, could adversely affect future growth and business objectives.
• Dependence on key personnel (e.g., Gary Seaton); loss of their services could adversely affect business operations and strategy.
• Potential for claims, litigation, or regulatory actions, including securities class action litigation, which could result in substantial costs and diversion of management attention.
• Retail price of products may be subject to control by government authorities, potentially leading to reduced profitability.
• Inability to maintain all required permits and licenses, or changes in renewal standards or new regulations, could severely disrupt business.
• Adverse publicity associated with products, raw materials, or top suppliers/customers could harm reputation and operating results.
• Inability to develop new products successfully or generate sufficient revenues from new products could adversely affect business.
• Geopolitical risks, including international conflicts (e.g., Ukraine, Middle East) and inflation, could negatively affect supply chain, orders, raw material prices, and overall economic conditions.
• Risks of natural disasters, epidemics, and other acts of God causing material damage to facilities, potentially not adequately covered by insurance.
• Risk of product contamination leading to product liability claims and recalls, despite insurance coverage.
• Failure to compete effectively in competitive markets, potentially leading to lower revenues and higher costs.
• The company's stock price may be volatile, and purchasers could incur substantial losses, especially given the small public float.
• Inability to maintain Nasdaq listing due to minimum bid price non-compliance or other listing requirements, which could adversely affect liquidity and financing ability.
• Principal shareholders (JSKS Enterprises, controlled by Gary Seaton) have significant influence over corporate actions, potentially delaying or preventing acquisitions.
• Future sales of substantial amounts of Ordinary Shares by the company or existing shareholders could adversely affect the market price.
• Reduced reporting requirements as an emerging growth company and smaller reporting company may make Ordinary Shares less attractive to some investors.
• Anti-takeover provisions in corporate documents and Cayman Act could impair takeover attempts, limiting shareholder premium opportunities.
• The company may redeem unexpired Warrants prior to their exercise at a time disadvantageous to Warrant holders, potentially forcing exercise or acceptance of a nominal redemption price.
• The company's warrant agreement designates New York courts as the exclusive forum for certain actions, potentially limiting warrant holders' ability to obtain a favorable judicial forum.

Future Outlook

The company aims to become the largest cold-pressed producer in the Oceanic/APAC region by expanding its existing Cootamundra facility and constructing a new multi-seed crushing plant in Emerald, Queensland, which is expected to increase total capacity to 160,000 metric tons per annum. It projects to achieve AUD$2.4 million net profit before tax from July 2026 to June 2026, subject to market and weather conditions. The company intends to fund its capital expenditures and working capital through operating cash flow, additional long-term debt from Commonwealth Bank of Australia (AUD$8 million unused facility), and potentially drawing down an additional US$6 million from existing PIPE investors or utilizing the US$50 million equity line of credit (ELOC).

Management Comments

• "The Company believes that transitioning from a fossil fuel economy to a renewable and chemical free economy is the solution to many health problems the world is facing presently."
• "To that end, the Company is committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils to customers globally."
• "The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq's continued listing requirement."
• "The Company has determined that the Company's sources of liquidity will be sufficient to meet the Company's financing requirements for the one-year period from the issuance of its consolidated financial statements."
• "Management has considered and determined that there will not be a material increase in capital expenditures or operating costs associated with climate-related matters, including costs and expenditures incurred to mitigate the physical effects of climate change or incurred in connection with any plans they may have to reduce emissions or their reliance on carbon-based energy."
• "The Company believes its relationship with its employees and contractors is cooperative and its employees and contractors share the same goals as management to industrialize oilseeds, making the products available worldwide."

Industry Context

The global oilseeds market is projected to grow significantly, from an estimated US$264.87 billion in 2022 to US$385.45 billion by 2030, driven by increasing usage in animal feed and demand for healthy/organic oilseed-processed goods. The non-GMO food market is also experiencing rapid growth, valued at US$740.65 billion in 2023 and projected to reach US$2,003.68 billion by 2032 (CAGR of 11.94%). Australian-derived non-GMO oils are in high demand, particularly in Europe and Asia-Pacific, contrasting with genetically modified alternatives. The company's focus on cold-pressed, chemical-free, non-GMO products aligns with these trends, aiming to capitalize on the increasing consumer preference for healthier and sustainable food options. The expansion into Central Queensland is strategically placed to revive the local oilseed industry and tap into the Asia-Pacific market, which is expected to grow at a CAGR of 37.7% from 2024 to 2033.

Comparison to Industry Standards

• The company claims to be the 'largest cold pressing oil plant in Australia' with a current processing capacity of more than 33,000 metric tons per annum, and plans to expand to 160,000 metric tons, positioning itself as the 'largest cold-pressed player in the APAC region'. This scale, if achieved, would be significant within the regional cold-pressed oil sector.
• The company's focus on non-GMO and chemical-free products, along with regenerative farming practices, aligns with the growing global non-GMO food market, which is projected to reach US$2,003.68 billion by 2032. This indicates a strong market niche compared to conventional oil producers.
• The company's sales contracts with major Australian supermarket chains like Costco, Woolworths, and Coles demonstrate successful penetration into established retail channels, which is a key indicator of market acceptance for consumer goods.
• The company's financial performance, with a net loss of AUD$33.7 million in FY2024 and increasing losses in Q3 FY2025, contrasts sharply with the profitability of more established, diversified food processing companies. Its net current liability position of AUD$9.6 million as of March 31, 2025, is a significant concern compared to financially stable industry peers.
• The Nasdaq minimum bid price deficiency (below $1) indicates a struggle to maintain market valuation and investor confidence, which is below the standards expected of publicly traded companies on major exchanges.
• The company's reliance on a few key customers (top five accounted for 87.9% of Q3 FY2025 sales) is a higher concentration risk than typically seen in mature, diversified food processing companies, which usually have a broader customer base to mitigate revenue volatility.

Management Changes

Corporate Governance

Legal Proceedings

• Two litigation claims filed against subsidiaries Cowcumbla Investments Pty Ltd. and Cootamundra Oilseeds Pty Ltd. in the Supreme Court of New South Wales, related to a AUD$1.2 million related party loan with a former director, were settled. The amount due was repaid from January to April 2023, with an additional AUD$95,000 paid as final settlement on June 1, 2023. The company does not expect further costs related to this matter.

Related Party Transactions

• A related party loan is owed to JSKS Enterprises Pty Ltd. (trustee of Gary Seaton Family Trust, controlled by CEO Gary Seaton) with a 6% per annum interest rate, repayable within 12 months after year-end, with remaining principal repayable after 12 months. As of March 31, 2025, AUD$1,050,825 is current and AUD$3,932,742 is non-current (including AUD$1,050,824 accrued interest).
• A related party loan is owed to Energreen Nutrition Australia Pty Ltd. (controlled by Gary Seaton) with a 6% per annum interest rate, expected to be repaid in full within 12 months after year-end. As of March 31, 2025, AUD$7,161,361 is current and AUD$989,473 is non-current.
• An interest-free loan is owed to CQ Oilseeds Pty Ltd. As of March 31, 2025, AUD$59,371 is non-current.
• The company purchases seeds from Energreen Nutrition Australia Pty Ltd. (AUD$7,222,239 for nine months ended March 31, 2025) and Soon Soon Oilmills Sdn Bhd. (AUD$374,819 for three months ended March 31, 2025, where Gary Seaton has a 20% share).
• Sales of meals to Energreen Nutrition Australia Pty Ltd. amounted to AUD$4,290,895 for the nine months ended March 31, 2025.
• Management fees of AUD$264,000 were paid to related parties for the nine months ended March 31, 2025.
• Lease payments to Energreen Nutrition Australia Pty Ltd. and Sunmania Pty Ltd. (AUD$7,968 and AUD$56,000 respectively for nine months ended March 31, 2025).
• On March 21, 2024, the company issued two promissory notes to American Physicians, LLC (shareholders from the Sponsor of EDOC) for USD$450,000 and USD$500,000, accruing interest at term SOFR. As of March 31, 2025, AUD$1,040,641 is current and AUD$273,676 is non-current (including AUD$49,928 accrued interest).
• The Board approved the conversion of JSKS loan amounting to AUD$4.9 million to 4,452,479 shares at USD$0.7241 per share, executed on May 22, 2025.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from the potential US$50 million equity line of credit and the conversion of related party loans into shares. Existing shareholders' economic and voting interests will be diluted. The Nasdaq minimum bid price deficiency poses a risk to liquidity and market price. The history of net losses and negative operating cash flow indicates a high-risk investment.
• **Employees**: The company's growth and expansion plans (Cootamundra and Queensland facilities) suggest potential job creation and stability, but the overall financial losses and going concern doubt could create uncertainty.
• **Customers**: New supply contracts with major supermarkets (Costco, Woolworths, Coles) indicate increased product availability and market penetration for consumers. However, the high concentration of revenue from a few key customers poses a risk if those relationships deteriorate.
• **Suppliers (Farmers)**: The company's dependence on local and regional farmers for oilseeds means their continued business is crucial. The commitment to sustainable and chemical-free farming methods benefits these specific growers.
• **Creditors**: The company's net current liability position and reliance on additional debt and equity funding to meet obligations indicate increased risk for creditors. The Commonwealth Bank of Australia has provided a significant facility, and promissory notes are outstanding.

Next Steps

• Regain compliance with Nasdaq's $1 minimum bid price requirement by evaluating options and timely regaining compliance.
• File additional registration statements with the SEC if more than 25,000,000 Ordinary Shares are to be sold to Arena under the Purchase Agreement.
• Continue construction of the new crushing and production plant in Emerald, Queensland, with groundbreaking expected in Q1 2025 calendar year and construction completion by December 2026.
• Secure AUD$8 million to AUD$11 million in equity funding for the Queensland plant, or fund the shortfall from operating cashflow.
• Continue to draw down additional long-term debt from Commonwealth Bank of Australia (AUD$8 million unused facility) and potentially US$6 million from existing PIPE investors.
• Renegotiate the renewal of the contract with Costco in November 2024.
• Work with Woolworth Grocery on the next major review to increase supply and range of oils under future contracts, including the anticipated commitment for 750mL Good Earth Oil Extra Virgin Vegetable Oil in March 2025 planogram.
• Continue to implement the remediation plan to address material weaknesses in internal control over financial reporting, including recruiting personnel, training staff, and engaging technical consultants.
• Monitor and manage compliance with banking covenants (interest cover ratio and net working capital ratio).

Key Dates

Recommendation

Keywords

Oilseeds, Cold-pressed oil, Non-GMO, Sustainable food, Edible oils, Protein meals, Agricultural products, Food processing, Nasdaq listing, SEC filing, Equity line of credit, SPAC merger, Financial performance, Australia, Queensland, Supply chain, Corporate governance, Risk management, Dilution, Warrants, Related party transactions